Summary
There were 40 virologically confirmed cases of dendritic keratitis treated in a randomized double-blind placebo-controlled study. After thermomechanical debridement of the corneal epithelium, the patients received two drops of human leukocyte interferon (HLI) twice daily. The activity was 3×106 units/ml. HLI significantly accelerated healing and inhibited virus shedding. It remains to be studied whether HLI will be equally effective in the prophylaxis of late herpes recurrences.
Zusammenfassung
40 Patienten mit virologisch gesicherter Keratitis dendritica wurden im Rahmen einer randomisierten, Placebo-kontrollierten Doppelblindstudie behandelt. Nach thermomechanischer Abrasio des Hornhautepithels erhielten sie zweimal täglich 2 Tropfen Humanleukozyteninterferon (HLI), dessen Aktivität 3×106 Einheiten/ml betrug. HLI beschleunigte signifikant die Heilung und unterbrach die weitere Virusvermehrung. Es bleibt zu prüfen, ob sich der gleiche gute Erfolg auch bei der Interferon-Prophylaxe herpetischer Spätrezidive zeigt.
Similar content being viewed by others
References
Cantell, K., Hirvonen, S., Mogensen, K.E., Pyhälä, L.: Human leukocyte interferon, production, purification, stability and animal experiments. In: Waymouth C. (Ed.), Proceedings of a Tissue Culture Association Workshop, In Vitro, pp. 35–38, monograph No 3, Rockville, Md. (1974)
Jones, B.R., Coster, D.J., Falcon, M.G., Cantell, K.: Clinical trials of topical interferon therapy of ulcerative viral keratitis. J. Infect. Dis. 133, A 13, Suppl., June 1976
Kaufman, H.E., Ellison, E.D., Centifanto, Y.M.: Difference in interferon response and protection from ocular virus infections in rabbits and monkeys. Amer. J. Ophthal. 74, 89–92 (1972)
Neumann-Haefelin, D., Sundmacher, R., Sauter, B., Karges, H.E., Manthey, K.F.: Effect of human leukocyte interferon on vaccinia- and herpes virus-infected cell cultures and monkey corneas. Infect. Immun. 12, 148–155 (1975)
Sundmacher, R., Neumann-Haefelin, D., Shrestha, B.: Die Wirkung von Human-Leukozyten-Interferon (HIF) auf experimentelle Viruskeratitiden bei Affen. Albrecht v. Graefes Arch. klin. exp. Ophthal. 195, 263–270 (1975)
Sundmacher, R., Neumann-Haefelin, D., Manthey, K.F., Müller, O.: Interferon in treatment of dendritic keratitis in humans. A preliminary report. J. Infect. Dis. 133, A 160 Suppl., June 1976
Sundmacher, R.: Herpestherapie und -prophylaxe. I. Versuch einer kritischen Wertung. Klin. Mbl. Augenheilk. (in press)
Symposium on antivirals with clinical potential, Stanford, August 26–29, 1975. J. Infect. Dis. 133, Suppl., June 1976
Tackett, L.L., Anderson, S.G.: Interferon standards, in Symp. series: Immunobiol. Standard. pp. 277–278, Basel: Karger, 1970
Weinberg, R.J., Oh, J.O.: The in vitro effect of a topical anesthetic, ophthaine, on types 1 and 2 herpes simplex virus. Sarasota: ARVO-meeting, 1975. Ann. Ophthal. (in press)
Author information
Authors and Affiliations
Additional information
This investigation was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 31, Medizinische Virologie.
Rights and permissions
About this article
Cite this article
Sundmacher, R., Neumann-Haefelin, D. & Cantell, K. Successful treatment of dendritic keratitis with human leukocyte interferon. Albrecht von Graefes Arch. Klin. Ophthalmol. 201, 39–45 (1976). https://doi.org/10.1007/BF00410146
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00410146